to High-Density Lipoprotein, Dyslipidemia, and Coronary Heart Disease -- Regulation of ApoA-I Gene Expression and Prospects to Increase Plasma ApoA-I and HDL Levels -- High Density Lipoprotein Particles -- The Kinetics and Remodeling of HDL Particles: Lessons from Inborn Errors of Lipid Metabolism -- HDL Structure, Function, and Antiinflammatory Properties -- Human Apolipoprotein A-I Deficiency -- Human Apolipoprotein A-I Mutants -- ATP Binding Cassette A1 Transporter Function and Tangier Disease -- The Role ABCG1 in Cellular Cholesterol Efflux: Relevance to Atherosclerosis and Endothelial Function -- In Vitro Studies and Mass Flux of Cholesterol Between Serum and Macrophages -- Genetic LCAT Deficiency: Molecular Diagnosis, Plasma Lipids, and Atherosclerosis -- Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism -- The HDL Receptor SR-BI -- Genetic Loci Influencing Plasma High Density Lipoprotein Cholesterol Concentrations in Humans -- Nutritional and Lifestyle Factors and High-Density Lipoprotein Metabolism -- Effects of Ethanol Intake on High Density Lipoprotein Metabolism in Humans -- Effects of Estrogen on HDL Metabolism -- Effects of Niacin on HDL Metabolism -- Effects of Statins on HDL Metabolism -- Therapeutic Regulation of High-Density Lipoprotein Transport in the Metabolic Syndrome -- Effects of Cholesterol Ester Transfer Protein Inhibition on HDL Metabolism -- HDL Infusion Therapy -- High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future.